NCT03839667

Brief Summary

It is a multicenter, open-label, parallel-group, randomized controlled clinical trial, which is designed to enroll newly diagnosed type 2 diabetes patients with overweight or obesity. The patients are randomized to an intensive diet intervention (intermittent very-low -calorie diet), enhanced physical activity intervention (high-intensity interval training exercise prescription combined with resistance training) or standard education group (diabetes health education only, including lifestyle education and guidance) for 12 weeks. This trial will test the primary hypothesis of whether an intensive lifestyle treatment (diet or physical activity) is more effective than a standard education in glycemic control. The secondary hypotheses are to compare the intensive lifestyle treatment with a standard education on adipose distribution, metabolic parameters, metabolic molecules, Framingham Risk Scores, and quality of life, et al.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
326

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 6, 2019

Completed
1 day until next milestone

Study Start

First participant enrolled

January 7, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 15, 2019

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2021

Completed
4.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2026

Completed
Last Updated

February 12, 2026

Status Verified

February 1, 2026

Enrollment Period

2.4 years

First QC Date

January 6, 2019

Last Update Submit

February 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • change in HbA1C level (%)

    12 weeks

Secondary Outcomes (16)

  • change in HbA1C level (%)

    From enrollment to the end of follow-up at 5 years

  • proportion of reversal of diabetes

    From enrollment to the end of follow-up at 5 years

  • reduction in the dosage of hypoglycemic drugs

    From enrollment to the end of follow-up at 5 years

  • change in insulin sensitivity

    From enrollment to the end of follow-up at 5 years

  • change in islet β-cell function

    From enrollment to the end of follow-up at 5 years

  • +11 more secondary outcomes

Study Arms (3)

intensive diet intervention group

EXPERIMENTAL

The participants will be instructed to restrict the total daily calorie intake to 800 kcal by receiving the very-low-calorie meal replacement formula for 2 consecutive days per week. They will be allowed to maintain their normal diet in the remaining 5 days, but need to restrict total intake to 2000 kcal per day.

Behavioral: intensive diet intervention

Enhanced physical activity group

EXPERIMENTAL

the participants will take high-intensity exercise in accordance with High Intensity Interval Training (HIIT) prescriptions, with maximum heart rate and relative maximal oxygen uptake monitored. They will take both aerobic and resistance training exercise consecutively, and total training time will be expected to reach at least 150 minutes per week.

Behavioral: Enhanced physical activity intervention

Standard education group

EXPERIMENTAL

the participants will receive no extra intervention but diabetes health education, which will be carried out in large classrooms, in groups, and over the telephone. The education is mainly consisted of instructions on healthy diet and exercise plans, prevention for acute and chronic complications and self-glycemic monitoring.

Behavioral: Standard education

Interventions

the participants will be instructed to restrict the total daily calorie intake to 800 kcal by receiving the very-low-calorie meal replacement formula for 2 consecutive days per week. They will be allowed to maintain their normal diet in the remaining 5 days, but need to restrict total intake to 2000 kcal per day.

intensive diet intervention group

the participants will receive no extra intervention but diabetes health education, which will be carried out in large classrooms, in groups, and over the telephone. The education is mainly consisted of instructions on healthy diet and exercise plans, prevention for acute and chronic complications and self-glycemic monitoring.

Standard education group

the participants will take high-intensity exercise in accordance with High Intensity Interval Training (HIIT) prescriptions, with maximum heart rate and relative maximal oxygen uptake monitored. They will take both aerobic and resistance training exercise consecutively, and total training time will be expected to reach at least 150 minutes per week.

Enhanced physical activity group

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women aged 40-70 years;
  • Newly diagnosed type 2 diabetes
  • Duration of type 2 diabetes ≤ 2 years;
  • Antidiabetic treatment maintained for at least 6 weeks before recruitment;
  • %≤ HbA1c \< 9.0%;
  • Kg/m2 ≤ Body mass index (BMI) \<40 Kg/m2;

You may not qualify if:

  • History consistent with type 1 diabetes;
  • Insulin treatment;
  • Severe cardiovascular disease:
  • current angina
  • myocardial infarction within last six months
  • heart failure
  • symptomatic periphery vascular disease
  • Uncontrolled hypertension: systolic blood pressure \> 180 mmHg or diastolic blood pressure \> 100 mmHg;
  • Myocardial ischemia indicated by resting ECG;
  • Foot ulcers, peripheral neuropathy or skeletal disorders;
  • Taking high intensity exercise more than 75 minutes or moderate intensity exercise more than 150 minutes per week during the screening phase
  • Average weekly alcohol intake \>140 grams for men and \>70 grams for women;
  • ALT or AST levels more than twice the upper limit of the normal range or active liver diseases;
  • eGFR \<60 ml/min/1.73 m2, or serum creatinine \>1.5 mg/dl for men or 1.3mg/dl for women; or Proteinuria
  • Malignant tumor in active-stage, or in remission stage but less than 5 years from the most recent treatment
  • +15 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ruijin hospital, Shanghai Jiaotong University School of Medicine

Shanghai, Shanghai Municipality, 200025, China

Location

Study Officials

  • Guang Ning, MD, PhD

    Shanghai Jiao Tong University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 6, 2019

First Posted

February 15, 2019

Study Start

January 7, 2019

Primary Completion

June 17, 2021

Study Completion

March 21, 2026

Last Updated

February 12, 2026

Record last verified: 2026-02

Locations